Moreover, the levels of PSA were investigated in breast cancer patients, and shown to decrease with advanced breast cancer stages, and to be able to better predict disease in pre-menopausal women compared to post-menopausal women [69]. This evidence concerns the gene KLK3 and breast carcinoma.